Clinical Trial

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Name: Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors — clinical trial record (NCT06993844)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

Phase 1/2, open-label study of ETX-636 in participants with advanced solid tumors

Protocol Amendment History 1 change

notable Trial sites expanded: 10 -> 15 locations 2026-05-07

Trial Details

NCT Number	NCT06993844
Lead Sponsor	Ensem Therapeutics
Conditions	Advanced Solid Tumors, Advanced Breast Cancer
Enrollment	233 participants
Start Date	2025-06-10
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-23